TRIL
Trillium Therapeutics Inc.
TRIL
TRIL
Delisted
TRIL was delisted on the 16th of November, 2021.
19 hedge funds and large institutions have $2.2M invested in Trillium Therapeutics Inc. in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 7 closing their positions.
Holders
19
Holders Change
-5
Holders Change %
-20.83%
% of All Funds
0.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$343K |
| 2 |
2
Geode Capital Management
Boston,
Massachusetts
|
$33K |
| 3 |
RIA
3
Realta Investment Advisors
Wilmington,
Delaware
|
$11K |
| 4 |
VF
4
Virtu Financial
New York
|
$6K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
CFGS
26
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
27
Bank of America
Charlotte,
North Carolina
| $0 | 250 | +150 | +150% |
|